Reductil Reviews

Reductil Reviews Reductil (generic name: Sibutramine) is manufactured and distributed by Abbott Pharmaceuticals, as an anti-obesity prescription drug. It is given to patients who are considered clinically obese, with a Body Mass Index (BMI) of 30 kg/m2 and above, as well as for patients who suffer from obesity related Type II diabetes. It is known as Meridia in the US and belongs to the category of SNRI (Serotonin-Noradrenaline Re-uptake Inhibitor). This appetite suppressant comes in 5, 10 and 15 mg capsules. It should be taken once a day with or without food.

Reductil can only be purchased with a doctor’s prescription and only for a short term period, usually a year. If taken to complement a diet and exercise plan, the user can see an average of at least five pounds lost on the first month. It is not recommended for high risk patients such as those afflicted with heart and kidney disease as well as those with hypertension. Children and teenagers below the age of 16, women who are pregnant or lactating should not take Reductil because of the effects of SNRI on the body.

Early this year, all Reductil products were banned for sale in the UK, as ordered by the European Medicines Agency (EMA) due to the results of a study involving 9,800 patients where the risks of using sibutramine, such as heart attacks and strokes were found to far outweigh its benefits.

Reductil Side Effects

Since Reductil is an SNRI, it acts to increase the two hormones responsible for mood changes, the serotonin and norephinephrine levels in the brain. SNRIs are often used as anti-depressants, and their side effect is loss of appetite, which works well for people who are trying to lose weight. However, other side effects may also include headaches, nausea, sexual dysfunction, urinary retention, sleeplessness, increased blood pressure and rapid heartbeats. Thus, patients with histories of hypertension, stroke and heart attacks are not advised to take this medication.

With the recent ban of Reductil in the UK, the US Food and Drug Administration (FDA) has called for addition of other contraindications to Reductil’s label, which further restricts this drug’s prescription to obese people who may already be taking medications for other diseases such as hypertension and kidney diseases.

Reductil Drawbacks

SNRIs increase the level of adrenaline in the body, and although this can provide more energy, uncontrolled and sudden adrenaline increases can also elevate blood pressure. Also, considering that Reductil can not be used alongside medications prescribed for other diseases, this weight loss drug has very limited use for obese people who often have other medical conditions.

Reductil can not be used for permanent weight loss, because of its health risks. This appetite suppressant can be bought with a doctor’s prescription only from drugstores and online stores. There is no detailed description of Reductil on an official website, that shows its positive effects on people trying to lose weight, nor are there testimonials available to vouch for its efficacy and safety. No 100% money back guarantee is given by the manufacturers that will assure users that it will work.

Conclusion

Being a prescribed only weight loss pill limits the use of Reductil and the health risks mentioned above outweigh the minimal benefits of this drug on people who are trying to lose weight. The recent UK ban on Reductil simply shows that this diet drug should be used with caution, especially since there are no money-back guarantees provided to consumers.
Phen375 Reviews

The better choice when it comes to appetite suppressants is Phen375, which has passed clinical tests for efficacy and safety. It has more potency than Reductil, with no known side effects and has a full money-back guarantee for consumers. It has no contraindications with medications prescribed for other diseases, and is manufactured using pharmacy grade in FDA approved labs.

Read more on Phen375.

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Blogplay

Comments are closed.